Oki, Eiji http://orcid.org/0000-0002-9763-9366
Ota, Mitsuhiko
Nakanoko, Tomonori
Tanaka, Yasushi
Toyota, Satoshi
Hu, Qingjiang
Nakaji, Yu
Nakanishi, Ryota
Ando, Koji
Kimura, Yasue
Hisamatsu, Yuichi
Mimori, Koshi
Takahashi, Yoshiya
Morohashi, Hajime
Kanno, Takahiro
Tadano, Kotaro
Kawashima, Kenji
Takano, Hironobu
Ebihara, Yuma
Shiota, Masaki
Inokuchi, Junichi
Eto, Masatoshi
Yoshizumi, Tomoharu
Hakamada, Kenichi
Hirano, Satoshi
Mori, Masaki
Funding for this research was provided by:
AMED (JP21hs0122001h0002)
Article History
Received: 5 September 2022
Accepted: 1 April 2023
First Online: 1 May 2023
Declarations
:
: Drs. Eiji Oki, Mitsuhiko Ota, Tomonori Nakanoko, Yasushi Tanaka, Satoshi Toyota, Qingjiang Hu, Yu Nakaji, Ryota Nakanishi, Koji Ando, Yasue Kimura, Yuichi Hisamatsu, Koshi Mimori, Yoshiya Takahashi, Hajime Morohashi, Kotaro Tadano, Hironobu Takano, Yuma Ebihara, Masaki Shiota, Junichi Inokuchi, Masatoshi Eto, Tomoharu Yoshizumi, Satoshi Hirano, and Masaki Mori have no conflicts of interest or financial ties to disclose. Takahiro Kanno and Kenji Kawashima received stock options from Riverfield, Inc. Kenichi Hakamada has received research funding from AMED and honoraria for lectures and manuscripts from the following organizations: Japan Medical Association, Keidanren, NTT East Corporation, Nankodo, Tokyo Igakusha, and Medical Sciences International.
Free to read: This content has been made available to all.